Find trials
Search tips

Collaborative for Longitudinal Aortic Imaging in the Young for Modeling and Decision Making for Hereditary Thoracic Aortic Disease

Overview

About this study

The purpose of this study is to determine if  the net long-term health benefits of surgical interventions for HTAD will vary significantly among individuals depending on their genotype, age, sex, and imaging biomarkers like aortic size and vertebral artery tortuosity index, and that these factors need to be explicitly included in the selection of an optimal treatment choice for an individual patient.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with a genetic diagnosis known to be associated with aortic or arterial disease, aortic disease or bicuspid aortic valve.

Exclusion Criteria:

  • Does not meet inclusion critieria.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 4/25/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Talha Niaz, M.B.B.S.

Contact us for the latest status

Contact information:

Katrina Olson CCRP

(507) 266-1078

olson.katrina@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20594687

Mayo Clinic Footer